Approval concludes nearly 40-year epic journey from fundamental research to discovery of an effective treatment for active relapsing multiple...
Phase III clinical trials for new MS drug very positive.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to...
Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.